Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma. - Zugasti I; Tormo-Ratera M; Oliver-Caldés A; Soler-Perromat JC; González-Calle V; Moreno DF; Cabañas V; López-Muñoz N; Bartolomé-Solanas Á; Español-Rego M; Reguera-Ortega JL; Rosiñol L; et al. (Blood advances, 2025)